Discover 1,414 paid clinical trials in Renton, Washington. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,414
Featured
Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients
for
Bipolar Depression
Location: 35 recruiting locations
Sponsor: Intra-Cellular Therapies, Inc.
Sex: All
Age: 10 - 17
Code: NCT06372964
Phase3, Recruiting
Active & Responsive
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants
for
Hypothyroidism
Location: 109 recruiting locations
Sponsor: AbbVie
Sex: All
Age: 18 - 70+
Code: NCT06345339
Phase2, Phase3, Recruiting
Active & Responsive
Assessment of Early Pregnancy MAB Completion
for
Pregnancy, Abortion Early
Location: 3 recruiting locations
Sponsor: University of Washington
Sex: Female
Age: 0+
Code: NCT06893484
Recruiting
Active & Responsive
National Cancer Institute "Cancer Moonshot Biobank"
for
Acute Myeloid Leukemia,
Location: 109 recruiting locations
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 13+
Code: NCT04314401
Recruiting
Active & Responsive
A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression
for
Treatment Resistant Depression
Location: 51 recruiting locations
Sponsor: LivaNova
Sex: All
Age: 18+
Code: NCT03887715
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
for
Psoriasis, Overweight or Obesity
Location: 41 recruiting locations
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT06857942
Recruiting
Active & Responsive
VOICE-Early Response to Vedolizumab and IL-23 Antagonists in Participants With Crohn's Disease: A Prospective Observational Study
for
Crohn's Disease
Location: 21 recruiting locations
Sponsor: Alimentiv Inc.
Sex: All
Age: 18+
Code: NCT06249555
Recruiting
Active & Responsive
A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)
for
Treatment Resistant Depression
Location: 32 recruiting locations
Sponsor: atai Therapeutics, Inc.
Sex: All
Age: 18 - 65
Code: NCT06524830
Phase2, Recruiting
Active & Responsive
Secukinumab Open Label Roll-over Extension Protocol
for
Autoimmunity, Inflammation
Location: 8 recruiting locations
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 6 - 70+
Code: NCT04638647
Recruiting
Active & Responsive
The GORE® VIABAHN® FORTEGRA Venous Stent Iliofemoral Study
for
Venous Thromboses, Venous Disease, Venous Leg Ulcer,